Pharmaceutical Packaging Market

Pharmaceutical Packaging Market by Type (Plastic Bottles, Blister Packs, Labels & Accessories, Caps & Closures, Pre-filled Syringes, Vials, Ampoules), Raw Material, Drug Delivery Mode (Oral Drugs, Injectables, IV Drugs), Region - Global Forecast to 2024

Report Code: CH 3482 Oct, 2019, by marketsandmarkets.com
Updated date -

[160 Pages Report] The pharmaceutical packaging market size is estimated to be USD 83.6 billion in 2019 and is projected to reach USD 111.9 billion by 2024, at a CAGR of 6.0%. The growing demand for drug delivery devices and blister packaging in emerging economies is expected to drive the market between 2019 and 2024. Also, novel drug developments such as nanotechnology and nanomedicines, leading to packaging innovations is likely to propel the pharmaceutical packaging market in the next five years.

Pharmaceutical Packaging Market

Market Dynamics

Growing pharmaceutical industry in emerging economies

The pharmaceutical packaging industry is growing at a rapid pace in emerging economies. Advanced manufacturing processes, technological innovations, and increased integration of companies have resulted in the rapid growth of the industry. This growth of the pharmaceutical industry is driving the pharmaceutical packaging market. The growth is expected to be the highest in emerging economies such as Brazil, Russia, India, and China. Increasing income levels and growing awareness about the advantages of good healthcare systems and healthier lifestyles is supporting the growth of the market in these countries. Large population and demographic factors such as growing young population and higher life expectancy are also the key drivers of this growth. According to the World Bank, healthcare expenditure of Brazil, China, and India was around 11.8%, 5.0%, and 3.7% of the GDP in 2016, which was a substantial increase from 2015.

As the developed markets (US, UK, Germany, France, and Italy) become saturated, pharmaceutical companies are aligning their growth strategies largely on the rapidly expanding emerging markets, especially the BRIC countries. The market expansion, increasing aging population, clinical and technological advances, and rising expenses in public healthcare systems are providing opportunities for pharmaceutical companies to expand in this region. This is, subsequently, propelling the pharmaceutical packaging market.

Increasing overall packaging costs owing to dynamic regulatory policies

The demand for pharmaceutical packaging continues to increase with the growth of the pharmaceutical Industry. However, its growth is likely to be hampered by the high cost of manufacturing. Owing to the need for longer shelf-life and to comply to stringent safety standards set by regulators such as the US Food and Drug Administration (FDA), European Medicines Agency (EMA), and Heads of Medicines Agencies (HMA), packaging suppliers have to put more effort to streamline their manufacturing process and produce error-free packaging products. These stakeholders have to add value, adhere to rules, and ensure regulatory compliance. The type and design of packaging material are also influenced by market conditions and strictly regulated by a number of regulatory policies.

Pharmaceutical packaging is designed to protect the drug from environmental conditions, mechanical damage, and natural and human hazards. At the same time, it is required to be child-resistant and leakage proof. Meeting all these requirements involve high costs in the production of pharmaceutical packaging.

The following factors increase the cost of pharmaceutical packaging:

  • Incorporating compliance solutions in primary and secondary packs
  • Increase in tamper-resistant and anti-counterfeiting features
  • Using track and trace technologies such as serialization solutions
  • Developing child-proof and senior-friendly packaging
  • Use of sustainable raw materials and packaging manufacturing methods

Thus, with increasing complexity in designing pharmaceutical packaging, companies are compelled to use high-cost machinery and technology to create efficient packaging solutions.

Expanding 3PL and other services in emerging markets

Third-party logistics (3PL) are businesses which provide transportation or freight management, warehousing, distribution management, and freight consolidation. Companies involved in 3PL are responsible for distributing, safeguarding, and proper storage of pharmaceutical products until they reach the designated customer such as importer, convertor, and so on. These services have the highest growth potential in the rapidly growing and emerging markets such as BRIC countries, Saudi Arabia, the UAE, South Africa, and Turkey.

Markets in the emerging economies have a large number of distributors. This increases the risk of improper handling of pharmaceutical products owing to lack of proper knowledge on ‘Last Mile’ logistics and handling. Many countries are now streamlining this process by introducing various norms. For instance, in 2018, China introduced the Two Invoice System, which requires that there be only one distributor with proper logistic knowledge between the manufacturer and importer to curb mismanagement. Leading logistics service providers such as DHL (Germany), UPS (US), Kuehne & Nagel (Switzerland), Expeditors International of Washington (US), FedEx (US), and Imperial Logistics (South Africa) are working in association with pharmaceutical and packaging industries on the supply chain and other services.

3PL service providers are acting as major collaborators in the distribution of pharmaceutical products, offering services and solutions for warehousing, pick/pack, track-n-trace, time-critical, and temperature-controlled facilities. In addition, incorporation of blockchain technology and automation & digitization of supply chain will play a major role in the coming years and, in turn, boost 3PL services. These advancements in 3PL service will benefit pharmaceutical packaging companies with the opportunity to share resources and cater to the needs of the emerging markets efficiently.

By type, the plastic bottle is expected to account for the largest share, in the pharmaceutical packaging market during the forecast period.

Major drivers for the plastic bottle segment include properties such as lightweight and shatter resistance. Additionally, the suitability of plastic bottles to store solid, liquid & powdered medication and rise in use of oral drug delivery method is responsible for boosting the demand of plastic bottle for pharmaceutical packaging during the forecast period.

By raw material, plastic & polymers are expected to be the largest and fastest-growing segment, in the pharmaceutical packaging market during the forecast period.

Plastic & polymers are expected to account for the largest market share in the pharmaceutical packaging market, globally. It is also the fastest-growing raw-material segment, and the growth can be attributed to the compatibility of plastics in any form such as blisters, bottles, laminates, and others. Also, easy moldability, excellent gas & vapor barrier, and cost-effective protection against breakage losses make plastic widely used raw material for pharmaceutical packaging.

By drug delivery mode, oral drug delivery mode is expected to be the largest segment, in the pharmaceutical packaging market during the forecast period.

Oral drug delivery is projected to be the largest drug delivery mode during the forecast period. The growth of this segment can be attributed to patient convenience, flexibility in designing dosage, and cost-effective production.

Pharmaceutical Packaging Market

North America is projected to be the largest market during the forecast period.

North America is projected to be the largest pharmaceutical packaging market during the forecast period. This growth is attributed primarily to the new drug developments, technological advancements such as nanomedicines and biologics in the region. Also, the improved healthcare coverage, alterations in business models such as third party partnership and externalized R&D in the pharmaceutical industry is expected to boost the demand for pharmaceutical packaging. Moreover, growth in chronic disease owing to the rising percentage of the aging population is also responsible for the high growth of this region in the pharmaceutical packaging market.

Key Market Players

Berry Global, Inc.(US), Gerresheimer AG (Germany),  Amcor plc (Australia), Schott AG (Germany), AptarGroup, Inc. (US),  West Pharmaceutical Services, Inc. (US), Becton, Dickinson, and Company (US), Nipro Corporation (Japan), Catalent, Inc. (US) and WestRock Company (US) are some of the key players in the market.

These companies have adopted various organic and inorganic growth strategies between 2016 and 2019 to strengthen their position in the market. New product development and investment & expansion were among the key growth strategies adopted by these leading players to establish and enhance their regional presence to meet the growing demand for pharmaceutical packaging from the emerging economies.

Scope of the Report

Report Metric

Details

Years Considered for the study

  • 2017–2024

Base year

 2018

Forecast period

2019–2024

Units considered

Value (USD Million)

Segments

Type, Raw Material, Drug-delivery Mode and Region

Regions

North America, Europe, APAC,  South America  and  Middle East & Africa

Companies

Berry Global Inc. (US), Amcor plc (Australia), Gerresheimer AG (Germany), Schott AG (Germany) and AptarGroup, Inc. (Us), Total 25 major players covered

This research report categorizes the pharmaceutical packaging market based on type, raw material, drug-delivery mode, and region.

Based on type, the pharmaceutical packaging market has been segmented as follows:

  •  Plastic bottles
  •  Blister packs
  •  Labels & accessories
  •  Caps & closures
  •  Pre-fillable syringes
  •  Medical specialty bags
  •  Temperature-controlled packaging
  •  Pouches & strip packs
  •  Pre-filled inhalers
  •  Vials
  •  Ampoules
  •  Medication tubes
  •  Jars & canisters
  •  Cartridges
  •  Others (paperboard boxes, corrugated boxes, and trays)

Based on raw material, the pharmaceutical packaging market has been segmented as follows: 

  • Plastics & Polymers
  • Paper & paperboards
  • Glass
  • Metals
  • Others (rubber and steel)

Based on drug-delivery mode, the pharmaceutical packaging market has been segmented as follows:

  • Oral Drugs
  • Pulmonary
  • Transdermal
  • Injectables
  • Topical 
  • Nasal 
  • Ocular/ Ophthalmic
  • IV Drugs
  • Others (targeted drug delivery, carrier-based drug delivery, nanoparticle drug delivery, and genetic transfer)

Based on region, the pharmaceutical packaging market has been segmented as follows:

  • North America
  • Europe
  • APAC
  • South America
  • Middle East & Africa

Recent Developments

  • In July 2019, Berry Global announced the acquisition of RPC Group PLC (UK), a major provider of rigid packaging to the wide range of end-use industries such as food, healthcare, beverage, and others. This acquisition will enable Berry to capture higher market share.
  • In June 2019, Amcor (Australia) acquired Bemis (US), a strong player in flexible packaging product manufacturing. Through this acquisition, Amcor can capitalize on the capability to serve its customer base and will strengthen its position in the competitive market.
  • In March 2019, Schott developed Everic vials for packaging of small volumes of sensitive drugs. This product benefitted to end-user with its quality fill and finish and is suitable for highly potent drugs such as biologics.
  • In March 2019, Gerresheimer announced a plan to invest for a new plant in Skopje, North Macedonia. The plant will manufacture plastic systems such as pre-fillable syringes and will start operating from the second half of 2020. This investment will reinforce the company’s strategy to expand the production network in Europe.

Critical questions the report answers:

  • What are the upcoming hot bets for the pharmaceutical packaging market?
  • How are the market dynamics for different types of pharmaceutical packaging?
  • What are the significant trends in pharmaceutical drug development industry influencing the market?
  • Who are the major manufacturers of pharmaceutical packaging?
  • What are the factors governing the pharmaceutical packaging market in each region?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 22)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Pharmaceutical Packaging Market Segmentation
           1.3.2 Regions Covered
           1.3.3 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 25)
    2.1 Research Data
           Figure 1 Pharmaceutical Packaging Market: Research Design
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Key Industry Insights
                    2.1.2.3 Breakdown of Primary Interviews
    2.2 Market Size Estimation
           2.2.1 Bottom-Up Approach
           2.2.2 Top-Down Approach
    2.3 Data Triangulation
           Figure 2 Pharmaceutical Packaging Market: Data Triangulation
    2.4 Assumptions
    2.5 Limitations

3 Executive Summary (Page No. - 32)
     Figure 3 Plastics & Polymers Was the Largest Raw Material Segment for Pharmaceutical Packaging in 2018
     Figure 4 Plastic Bottles to Be Largest Type of Pharmaceutical Packaging
     Figure 5 Oral Drug Delivery to Be Largest Drug Delivery Mode in Pharmaceutical Packaging
     Figure 6 APAC to Be the Fastest-Growing Pharmaceutical Packaging Market

4 Premium Insights (Page No. - 36)
    4.1 Attractive Opportunities in the Pharmaceutical Packaging Market
           Figure 7 Growth in Demand for Medicines and Related Packaging  in Pharmerging Economies to Drive the Market
    4.2 Pharmaceutical Packaging Market, By Material
           Figure 8 Plastics & Polymers to Be the Largest Raw Material Segment  in Overall Pharmaceutical Packaging
    4.3 Pharmaceutical Packaging Market, By Type
           Figure 9 Plastic Bottles to Be the Largest Packaging Type in Overall Packaging Market
    4.4 Pharmaceutical Packaging Market,  By Drug Delivery Mode
           Figure 10 Oral Drug Delivery to Be the Largest Segment in Overall  Packaging Market
    4.5 Pharmaceutical Packaging Market, By Region
           Figure 11 India to Be the Fastest-Growing Market in APAC
    4.6 North America Pharmaceutical Packaging Market,  By Type and Country
           Figure 12 Plastic Bottles Accounted for the Largest Market Share

5 Market Overview (Page No. - 39)
    5.1 Introduction
    5.2 Market Dynamics
           Figure 13 Drivers, Restraints, Opportunities, and Challenges in Pharmaceutical Packaging Market
           5.2.1 Drivers
                    5.2.1.1 Growing Pharmaceutical Industry in Emerging Economies
                    5.2.1.2 Growing Demand for Drug Delivery Devices and Blister Packaging
                    5.2.1.3 Technological Advancements to Contribute to the Growth  of Pharmaceutical Packaging
                    5.2.1.4 Growing Health Awareness and Adoption of  New Regulatory Standards
           5.2.2 Restraints
                    5.2.2.1 Increasing Overall Packaging Costs Owing to  Dynamic Regulatory Policies
                    5.2.2.2 Lack of Access and Awareness in Emerging Markets
           5.2.3 Opportunities
                    5.2.3.1 Growing Demand for Primary Pharmaceutical Packaging
                    5.2.3.2 Expanding 3pl and Other Services in Emerging Markets
           5.2.4 Challenges
                    5.2.4.1 Safeguarding Against Counterfeit Products
    5.3 Porter’s Five Forces Analysis
           Figure 14 Porter’s Five Forces Analysis: Pharmaceutical Packaging Market
           5.3.1 Threat of New Entrants
           5.3.2 Threat of Substitutes
           5.3.3 Bargaining Power of Buyers
           5.3.4 Bargaining Power of Suppliers
           5.3.5 Intensity of Competitive Rivalry

6 Pharmaceutical Packaging Market, By Type (Page No. - 48)
    6.1 Introduction
           Table 1 Pharmaceutical Packaging Market Size, By Region, 2017–2024 (USD Million)
           Table 2 Pharmaceutical Packaging Market Size, By Type, 2017–2024 (USD Million)
           Table 3 Pharmaceutical Packaging Market Size, By Packaging Type,  2017–2024 (USD Million)
           Figure 15 Plastic Bottles Account for Largest Share of Overall Pharmaceutical Packaging Market
    6.2 Plastic Bottles
           6.2.1 High Demand for Plastic Bottles Owing to Easy  Workability and Lightweight Property
                    Table 4 Plastic Bottles Market Size, By Region, 2017–2024 (USD Million)
           6.2.2 Standard Plastic Bottles
           6.2.3 Plastic Dispensing Bottles
           6.2.4 Plastic Jars
    6.3 Blister Packs
           6.3.1 Effective Drug Protection and Easy Manufacturing  to Drive the Blister Packs Market
                    Table 5 Blister Packaging Market Size, By Region, 2017–2024 (USD Million)
           6.3.2 Compartment Packs
           6.3.3 Wallet Packs
    6.4 Labels & Accessories
           6.4.1 Labels are Crucial in Ensuring Patient-Drug Communication Compliance
                    Table 6 Labels & Accessories Market Size, By Region, 2017–2024 (USD Million)
    6.5 Caps & Closures
           6.5.1 Plastic Caps & Closures are Expected to Witness  High Growth During the Forecast Period
                    Table 7 Caps & Closures Market Size, By Region, 2017–2024 (USD Million)
    6.6 Medical Specialty Bags
           6.6.1 Easy Handling and Disposable Characteristics are Increasing the Demand for Specialty Bags
                    Table 8 Medical Specialty Bags Market Size, By Region, 2017–2024 (USD Million)
    6.7 Pre-Filled Syringes
           6.7.1 Higher Patient Compliance and Increasing Aging Population are Driving the Demand for Pre-Filled Syringes
                    Table 9 Pre-Filled Syringes Market Size, By Region, 2017–2024 (USD Million)
    6.8 Temperature-Controlled Packaging
           6.8.1 Increased Manufacturing of Specialized Drugs Will Fuel the Market for Temperature-Controlled Packaging
                    Table 10 Temperature-Controlled Packaging Market Size, By Region,  2017–2024 (USD Million)
    6.9 Pouches & Strip Packs
           6.9.1 Increasing Demand for Standup Pouches Offers  Growth Prospects for Packaging Manufacturers
                    Table 11 Pouches & Strip Packs Market Size, By Region, 2017–2024 (USD Million)
    6.1 Ampoules
           6.10.1 Market for Ampoules in Developing Countries  Witnessing A Good Growth Rate
                     Table 12 Ampoules Market Size, By Region, 2017–2024 (USD Million)
    6.11 Vials
           6.11.1 Demand for Vials in Developed Countries Slowing Down
                     Table 13 Vials Market Size, By Region, 2017–2024 (USD Million)
    6.12 Pre-Filled Inhalers
           6.12.1 Higher Demand Owing to Increasing Cases of  Pulmonary Diseases Driving the Demand
                     Table 14 Pre-Filled Inhalers Market Size, By Region, 2017–2024 (USD Million)
           6.12.2 Metered Dose Inhalers
           6.12.3 Dry Powder Inhalers
    6.13 Medication Tubes
           6.13.1 Ease of Use is Driving Demand for Medication Tubes
                     Table 15 Medication Tubes Market Size, By Region, 2017–2024 (USD Million)
           6.13.2 Composite Tubes
           6.13.3 All-Plastic Tubes
           6.13.4 Collapsible Metal Tubes
    6.14 Jars & Canisters
           6.14.1 Canisters Help Extend Shelf-Life of Pharmaceutical Products
                     Table 16 Jars & Canisters Market Size, By Region, 2017–2024 (USD Million)
    6.15 Cartridges
           6.15.1 Increasing Use of Pre-Filled Syringes Driving the Demand
                     Table 17 Cartridges Market Size, By Region, 2017–2024 (USD Million)
    6.16 Others
                     Table 18 Others Market Size, By Region, 2017–2024 (USD Million)

7 Pharmaceutical Packaging Market, By Raw Material (Page No. - 63)
    7.1 Introduction
           Table 19 Basic Packaging Raw Material Used in Pharmaceutical Packaging
           Figure 16 Pharmaceutical Packaging Market, By Raw Material
           Table 20 Pharmaceutical Packaging Market Size, By Raw Material,  2017–2024 (USD Million)
           Table 21 Pharmaceutical Packaging Market Size (Raw Material), By Region,  2017–2024 (USD Million)
    7.2 Plastics & Polymers
           7.2.1 Excellent Shatter Resistant of Plastics & Polymers  Boosts Its Use in Primary Packaging
           7.2.2 High-Density Polyethylene
           7.2.3 Polyester
           7.2.4 Polypropylene
           7.2.5 Low-Density Polyethylene
           7.2.6 Polyvinyl Chloride
           7.2.7 Cyclic Olefin Copolymer
           7.2.8 Polyethylene Terephthalate
    7.3 Paper & Paperboards
           7.3.1 Innovations in Secondary Packaging to Propel  the Use of Paper & Paperboards
    7.4 Glass
           7.4.1 Excellent Chemical Resistance of Glass to Boost  Its Use in Primary Packaging
                    Table 22 Type of Glass Used for Different Packaging
    7.5 Metals
           7.5.1 Increasing Use of Aluminium for Blister Packaging  to Boost the Market for Metals Segment
    7.6 Others

8 Pharmaceutical Packaging Market,  By Drug Delivery Mode (Page No. - 71)
    8.1 Introduction
           Figure 17 Pharmaceutical Packaging Market, By Drug Delivery Mode  (2019–2024)
           Table 23 Pharmaceutical Packaging Market (Drug Delivery Mode), By Region,  2017–2024 (USD Million)
           Table 24 Pharmaceutical Packaging Market, By Drug Delivery Mode,  2017–2024 (USD Million)
    8.2 Oral Drug Delivery Packaging
           8.2.1 High Demand for Oral Drug Delivery Owing  to Ease of Usage
    8.3 Pulmonary Drug Delivery Packaging
           8.3.1 Increasing Cases of Lung-Related Diseases Driving Demand
    8.4 Transdermal Drug Delivery Packaging
           8.4.1 Increasing Small Dose Drug Usage Fueling Market  for Transdermal Drug Delivery Packaging
    8.5 Injectable Packaging
           8.5.1 Injectables Offer Improved Patient Compliance
    8.6 Topical Drug Delivery Packaging
           8.6.1 Prevalence of Skin Diseases Drives the Market  for Topical Drugs
    8.7 Nasal Drug Delivery Packaging
           8.7.1 Rapid Absorption and Faster Onset of Action Propelling the Use of Nasal Drug Systems
    8.8 Ocular Drug Delivery Packaging
           8.8.1 Increasing Prevalence of Eye Disorders in the Aging Population Expected to Fuel the Consumption  of Ocular Drugs Packaging
    8.9 Iv Drugs Delivery Packaging
           8.9.1 Growing Use Due to Improved Patient Compliance and  High Drug Dose Capability Driving the Demand
    8.1 Other Drugs Delivery Packaging

9 Pharmaceutical Packaging Market, By Region (Page No. - 77)
    9.1 Introduction
           Figure 18 Pharmaceutical Packaging Market in India Will Register  the Highest Cagr
           Table 25 Pharmaceutical Packaging Market Size, By Region, 2017–2024 (USD Million)
    9.2 North America
           Figure 19 North America: Pharmaceutical Packaging Market Snapshot
           Table 26 North America: Pharmaceutical Packaging Market Size, By Country,  2017–2024 (USD Million)
           Table 27 North America: Pharmaceutical Packaging Market Size, By Type,  2017–2024 (USD Million)
           Table 28 North America: Pharmaceutical Packaging Market Size, By Packaging Type, 2017–2024 (USD Million)
           9.2.1 US
                    9.2.1.1 The US Pharmaceutical Packaging Market has Reached  New Heights With Rapid Technological Advancements
                               Table 29 US: Pharmaceutical Packaging Market Size, By Type, 2017–2024 (USD Million)
           9.2.2 Canada
                    9.2.2.1 The Country Provides A Competitive Business Environment for Pharmaceutical Packaging Manufacturers
                               Table 30 Canada: Pharmaceutical Packaging Market Size, By Type,  2017–2024 (USD Million)
           9.2.3 Mexico
                    9.2.3.1 Government Initiatives in the Healthcare Industry are Aiding  High Demand for Pharmaceutical Packaging
                               Table 31 Mexico: Pharmaceutical Packaging Market Size, By Type,  2017–2024 (USD Million)
    9.3 Europe
           Figure 20 Europe: Pharmaceutical Packaging Market Snapshot
           Table 32 Europe: Pharmaceutical Packaging Market Size, By Country,  2017–2024 (USD Million)
           Table 33 Europe: Pharmaceutical Packaging Market Size, By Type,  2017–2024 (USD Million)
           Table 34 Europe: Pharmaceutical Packaging Market Size, By Packaging Type,  2017–2024 (USD Million)
           9.3.1 Germany
                    9.3.1.1 Need for Advanced Drug Delivery Systems Due to the Increasing Aging Population and Non-Communicable Diseases is the Main Reason for the Growth of the Pharmaceutical Packaging Market
                               Table 35 Germany: Pharmaceutical Packaging Market Size, By Type,  2017–2024 (USD Million)
           9.3.2 France
                    9.3.2.1 The Demand for Generic Drugs in the Country is Growing
                               Table 36 France: Pharmaceutical Packaging Market Size, By Type,  2017–2024 (USD Million)
           9.3.3 Italy
                    9.3.3.1 Growing Exports of Pharmaceuticals Have A Significant  Impact on the Market
                               Table 37 Italy: Pharmaceutical Packaging Market Size, By Type,  2017–2024 (USD Million)
           9.3.4 UK
                    9.3.4.1 Innovations in the Pharmaceutical Industry are Increasing  the Demand for Pharmaceutical Packaging
                               Table 38 UK: Pharmaceutical Packaging Market Size, By Type, 2017–2024 (USD Million)
           9.3.5 Spain
                    9.3.5.1 Government Initiatives in the Healthcare Sector Will  Boost the Demand for Pharmaceutical Packaging
                               Table 39 Spain: Pharmaceutical Packaging Market Size, By Type,  2017–2024 (USD Million)
           9.3.6 Russia
                    9.3.6.1 Government Initiatives for Domestic Production of Pharmaceuticals are Driving the Pharmaceutical  Packaging Market
                               Table 40 Russia: Pharmaceutical Packaging Market Size, By Type,  2017–2024 (USD Million)
           9.3.7 Rest of Europe
                    Table 41 Rest of Europe: Pharmaceutical Packaging Market Size, By Type,  2017–2024 (USD Million)
    9.4 APAC
           Figure 21 APAC: Pharmaceutical Packaging Market Snapshot
           Table 42 APAC: Pharmaceutical Packaging Market Size, By Country,  2017–2024 (USD Million)
           Table 43 APAC: Pharmaceutical Packaging Market Size, By Type,  2017–2024 (USD Million)
           Table 44 APAC: Pharmaceutical Packaging Market Size, By Packaging Type,  2017–2024 (USD Million)
           9.4.1 China
                    9.4.1.1 The Government is Investing in R&D With A Special Focus  on Biologics and Biosimilar Drugs
                               Table 45 China: Pharmaceutical Packaging Market Size, By Type,  2017–2024 (USD Million)
           9.4.2 Japan
                    9.4.2.1 The Sizeable Aging Population is Increasing the  Demand for Medications
                               Table 46 Japan: Pharmaceutical Packaging Market Size, By Type,  2017–2024 (USD Million)
           9.4.3 South Korea
                    9.4.3.1 The Country has A Well-Developed Healthcare Industry and  Houses Major Pharmaceuticals Manufacturers
                    Table 47 South Korea: Pharmaceutical Packaging Market Size, By Type,  2017–2024 (USD Million)
           9.4.4 India
                    9.4.4.1 Large Domestic Consumption of Pharmaceuticals and Export of Generic Drugs are Driving the Pharmaceutical Packaging Market
                               Table 48 India: Pharmaceutical Packaging Market Size, By Type,  2017–2024 (USD Million)
           9.4.5 Australia
                    9.4.5.1 Schemes Such as Medicare and Pbs are Strengthening  the Country’s Pharmaceutical Industry
                               Table 49 Australia: Pharmaceutical Packaging Market Size, By Type,  2017–2024 (USD Million)
           9.4.6 Rest of APAC
                    Table 50 Rest of APAC: Pharmaceutical Packaging Market Size, By Type,  2017–2024 (USD Million)
    9.5 South America
           Table 51 South America: Pharmaceutical Packaging Market Size, By Country,  2017–2024 (USD Million)
           Table 52 South America: Pharmaceutical Packaging Market Size, By Type,  2017–2024 (USD Million)
           Table 53 South America: Pharmaceutical Packaging Market Size, By Packaging Type, 2017–2024 (USD Million)
           9.5.1 Brazil
                    9.5.1.1 Free and Universal Healthcare Services Supporting the  Growth of the Pharmaceutical Industry
                               Table 54 Brazil: Pharmaceutical Packaging Market Size, By Type,  2017–2024 (USD Million)
           9.5.2 Argentina
                    9.5.2.1 The Population has Good Access to Generic Drugs  Supported By Government Initiatives
                               Table 55 Argentina: Pharmaceutical Packaging Market Size, By Type,  2017–2024 (USD Million)
           9.5.3 Rest of South America
                    Table 56 Rest of South America: Pharmaceutical Packaging Market Size, By Type,  2017–2024 (USD Million)
    9.6 Middle East & Africa
           Table 57 Middle East & Africa: Pharmaceutical Packaging Market Size, By Country, 2017–2024 (USD Million)
           Table 58 Middle East & Africa: Pharmaceutical Packaging Market Size, By Type,  2017–2024 (USD Million)
           Table 59 Middle East & Africa: Pharmaceutical Packaging Market Size, By Packaging Type, 2017–2024 (USD Million)
           9.6.1 Saudi Arabia
                    9.6.1.1 Wider Access to Healthcare Services is Increasing the  Demand for Pharmaceuticals
                               Table 60 Saudi Arabia: Pharmaceutical Packaging Market Size, By Type,  2017–2024 (USD Million)
           9.6.2 South Africa
                    9.6.2.1 A Gradual Rise in Generic Drug Usage Will Fuel the  Pharmaceutical Packaging Market
                               Table 61 South Africa: Pharmaceutical Packaging Market Size, By Type,  2017–2024 (USD Thousand)
           9.6.3 Egypt
                    9.6.3.1 Increasing Domestic Production and Consumption of Pharmaceuticals Show Potential Market Growth
                               Table 62 Egypt: Pharmaceutical Packaging Market Size, By Type,  2017–2024 (USD Thousand)
           9.6.4 Rest of the Middle East & Africa
                            Table 63 Rest of the Middle East & Africa: Pharmaceutical Packaging Market Size,  By Type, 2017–2024 (USD Thousand)

10 Competitive Landscape (Page No. - 114)
     10 Competitive Landscape
           Figure 22 Companies Adopted Expansion, New Product Launch, and Acquisition as Key Strategies Between 2016 and 2019
           Figure 22 Companies Adopted Expansion, New Product Launch, and Acquisition as Key Strategies Between 2016 and 2019
             9.5.1 Brazil
                      9.5.1.1 Free and Universal Healthcare Services Supporting the  Growth of the Pharmaceutical Industry
                                 Table 54 Brazil: Pharmaceutical Packaging Market Size, By Type,  2017–2024 (USD Million)
             9.5.2 Argentina
                      Figure 23 Pharmaceutical Packaging Market: Competitive Leadership  Mapping, 2018
     Figure 23 Pharmaceutical Packaging Market: Competitive Leadership  Mapping, 2018
             9.5.3 Rest of South America
                      Table 56 Rest of South America: Pharmaceutical Packaging Market Size, By Type,  2017–2024 (USD Million)
     10.3.2 Business Strategy Excellence
               Table 57 Middle East & Africa: Pharmaceutical Packaging Market Size, By Country, 2017–2024 (USD Million)
               Table 58 Middle East & Africa: Pharmaceutical Packaging Market Size, By Type,  2017–2024 (USD Million)
               Table 59 Middle East & Africa: Pharmaceutical Packaging Market Size, By Packaging Type, 2017–2024 (USD Million)
             9.6.1 Saudi Arabia
             9.6.1.1 Wider Access to Healthcare Services is Increasing the  Demand for Pharmaceuticals
     10.4.5 Aptargroup, Inc.
             9.6.2 South Africa
                      Table 64 New Product Launch (2016–2019)
                      Table 61 South Africa: Pharmaceutical Packaging Market Size, By Type,  2017–2024 (USD Thousand)
                      Table 65 Investment & Expansion (2016–2019)
             9.6.3.1 Increasing Domestic Production and Consumption of Pharmaceuticals Show Potential Market Growth
                        Table 66 Merger & Acquisition (2016–2019)
             9.6.4 Rest of the Middle East & Africa
                        Table 67 Agreement & Collaboration (2016–2019)
             10 Competitive Landscape
                        Table 68 Joint Venture (2016–2019)

11 Company Profiles (Page No. - 128)
(Business Overview, Products & Services, Key Insights, Recent Developments, SWOT Analysis, MnM View)*
             11.1 Amcor PLC
                     Figure 24 Amcor: Company Snapshot
                     Figure 25 Amcor : SWOT Analysis
             11.2 Gerresheimer AG
                     Figure 26 Gerresheimer AG: Company Snapshot
                     Figure 27 Gerresheimer: SWOT Analysis
             11.3 Berry Global Inc.
                     Figure 28 Berry Global: Company Snapshot
                     Figure 29 Berry Global: SWOT Analysis
             11.4 Schott AG
                     Figure 30 Schott: Company Snapshot
                     Figure 31 Schott: SWOT Analysis
             11.5 Aptargroup, Inc.
                     Figure 32 Aptargroup: Company Snapshot
                     Figure 33 Aptargroup: SWOT Analysis
     11.11.16 Vetter Pharma International GmbH

12 Appendix (Page No. - 158)
     12 Appendix
     12.1 Discussion Guide
     12.2 Knowledge Store: Marketsandmarkets  Subscription Portal
     12.3 Available Customizations
     12.4 Related Reports

 

The study involved four major activities in estimating the current market size for pharmaceutical packaging. The exhaustive secondary research was done to collect information on the market, peer market, and parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, the market breakdown and data triangulation methodologies were used to estimate the market size of segments and subsegments.

Secondary Research

In the secondary research process, various secondary sources such as Hoovers, Bloomberg, and BusinessWeek were referred to for identifying and collecting information for this study. These secondary sources included annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold standard & silver standard websites, packaging related organizations, regulatory bodies, and databases.

Primary Research 

The pharmaceutical packaging market comprises several stakeholders such as raw material suppliers, distributors of pharmaceutical packaging, raw material associations, polymer and resin associations, pharmaceuticals and pharmaceutical packaging related associations, end-users of pharmaceutical packaging, and regulatory organizations in the supply chain. The demand side of this market consists of drug developers and medical institutions, whereas the supply side consists of packaging material manufacturers. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. Following is the breakdown of primary respondents

Pharmaceutical Packaging Market

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the pharmaceutical packaging market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and markets were identified through extensive secondary research.
  • The industry’s supply chain and market size, in terms of value, were determined through primary and secondary research.
  • All the percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources.

Data Triangulation

After arriving at the overall market size-using the estimation processes as explained above-the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the pharmaceutical packaging.

Objectives of the Study:

  • To define, describe, and forecast the size of the pharmaceutical packaging market in terms of value
  • To provide detailed information about the key factors (drivers, restraints, challenges, and opportunities) influencing the market
  • To analyze the market segmentation and forecast the pharmaceutical packaging market size based on type, raw material, and drug delivery
  • To forecast the market size with respect to four regions, namely, Asia Pacific (APAC), Europe, North America, the Middle East & Africa, and South America, along with their key countries
  • To strategically analyze micromarkets1 with respect to their individual growth trends, growth prospects, and their contribution to the overall market
  • To analyze the opportunities in the market for stakeholders and provide a competitive landscape for the market leaders
  • To analyze competitive developments such as new product development, investment & expansion, and merger & acquisition in the market
  • To strategically profile the key players and comprehensively analyze their market ranking and core competencies2

Notes: Micromarkets1 are defined as subsegments of the pharmaceutical packaging market included in the report.

Core competencies2 of the companies are determined in terms of their key developments, SWOT analysis, and strategies adopted to sustain their position in the market.

Available Customizations:

With the given market data, MarketsandMarkets offers customizations according to the company’s specific needs. The following customization options are available for the report:

Regional Analysis:

  • A country-level analysis of the pharmaceutical packaging market is provided based on the type of pharmaceutical packaging.

Company Information:

  • Detailed analysis and profiles of additional market players.
Report Code
CH 3482
Published ON
Oct, 2019
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Pharmaceutical Packaging Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

...

Digital Virtual Assistant - MarketsandMarkets

Home